Stay updated on Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial
Sign up to get notified when there's something new on the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page.

Latest updates to the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page
- Check2 days agoChange DetectedThe page revision indicator has advanced from v3.5.4 to v3.5.5, signaling a minor update to the page's metadata rather than changes to study details.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a new build/patch of the page rather than substantive content changes.SummaryDifference0.0%

- Check45 days agoChange DetectedUpdates the ClinicalTrials.gov page’s revision/version indicator from v3.5.0 to v3.5.3.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed.SummaryDifference0.0%

- Check95 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check116 days agoChange DetectedFallopian tube cancer is now listed as a condition on the page, and the page revision updated to v3.4.2 (replacing v3.4.1).SummaryDifference0.1%

Stay in the know with updates to Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page.